Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00799643
Show Display Options
Rank Status Study
1 Completed
Has Results
Targeting Inflammation Using Salsalate for Type 2 Diabetes-stage II
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Salsalate;   Drug: Salsalate Placebo

Indicates status has not been verified in more than two years